Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Extreme Networks
EXTR
$3.19B
| $1.75M | ﹤0.01% |
72,460
-326
| -0.4% | -$8.82K |
|
1927
Graham Holdings Company
GHC
$5.06B
| $1.75M | ﹤0.01% |
3,009
+58
| +2% | +$33.6K |
|
1928
Cameco
CCJ
$40.8B
| $1.75M | ﹤0.01% |
44,243
-22,168
| -33% | -$784K |
|
1929
iShare MSCI Eurozone ETF
EZU
$9.84B
| $1.75M | ﹤0.01% |
+41,393
| New | +$1.85M |
|
1930
Tandem Diabetes Care
TNDM
$1.29B
| $1.75M | ﹤0.01% |
84,140
+18,025
| +27% | +$495K |
|
1931
Armstrong World Industries
AWI
$7.78B
| $1.74M | ﹤0.01% |
24,225
+7,186
| +42% | +$536K |
|
1932
Trustmark
TRMK
$2.78B
| $1.74M | ﹤0.01% |
80,154
-9,024
| -10% | -$210K |
|
1933
NMI Holdings
NMIH
$3.31B
| $1.74M | ﹤0.01% |
64,235
-4,433
| -6% | -$123K |
|
1934
Arcosa
ACA
$7.12B
| $1.74M | ﹤0.01% |
24,132
-2,109
| -8% | -$160K |
|
1935
USA Compression Partners
USAC
$3.78B
| $1.73M | ﹤0.01% |
72,618
+70,282
| +3,009% | +$1.47M |
|
1936
Westamerica Bancorp
WABC
$1.38B
| $1.73M | ﹤0.01% |
40,005
-14,871
| -27% | -$665K |
|
1937
Warner Music
WMG
$13.8B
| $1.73M | ﹤0.01% |
55,084
-27,978
| -34% | -$877K |
|
1938
Enova International
ENVA
$6.37B
| $1.72M | ﹤0.01% |
33,880
-1,539
| -4% | -$80.3K |
|
|
ENV
1939
DELISTED
ENVESTNET, INC.
ENV
| $1.72M | ﹤0.01% |
39,035
-3,843
| -9% | -$211K |
|
|
CHS
1940
DELISTED
Chicos FAS, Inc.
CHS
| $1.72M | ﹤0.01% |
229,722
-20,539
| -8% | -$110K |
|
1941
First Bancorp
FBNC
$2.66B
| $1.7M | ﹤0.01% |
60,470
-5,184
| -8% | -$159K |
|
1942
Virgin Galactic
SPCE
$377M
| $1.7M | ﹤0.01% |
47,174
-11,710
| -20% | -$698K |
|
1943
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $1.7M | ﹤0.01% |
38,811
-2,721
| -7% | -$125K |
|
|
MORF
1944
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.7M | ﹤0.01% |
73,998
+7,004
| +10% | +$368K |
|
1945
Procept Biorobotics
PRCT
$1.15B
| $1.69M | ﹤0.01% |
51,613
+35,746
| +225% | +$1.22M |
|
1946
Concentrix
CNXC
$1.61B
| $1.69M | ﹤0.01% |
21,105
-7,705
| -27% | -$604K |
|
1947
QuantumScape Corp
QS
$3.4B
| $1.69M | ﹤0.01% |
252,648
-2,091,783
| -89% | -$17M |
|
1948
LXP Industrial Trust
LXP
$3.57B
| $1.69M | ﹤0.01% |
37,914
-4,965
| -12% | -$244K |
|
1949
Broadstone Net Lease
BNL
$4.06B
| $1.68M | ﹤0.01% |
117,390
-15,897
| -12% | -$254K |
|
1950
Dana Inc
DAN
$2.94B
| $1.67M | ﹤0.01% |
113,877
+22,273
| +24% | +$371K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.